BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23183351)

  • 1. Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia.
    Shojaei A; Ramezanzadeh M; Soleyman-Jahi S; Almasi-Nasrabadi M; Rezazadeh P; Eslani M
    J Cataract Refract Surg; 2013 Feb; 39(2):197-203. PubMed ID: 23183351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.
    Hofmeister EM; Bishop FM; Kaupp SE; Schallhorn SC
    J Cataract Refract Surg; 2013 Sep; 39(9):1358-65. PubMed ID: 23830559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mitomycin-C on tear film, corneal biomechanics, and surface irregularity in mild to moderate myopic surface ablation: preliminary results.
    Mohammadi SF; Ashrafi E; Norouzi N; Abdolahinia T; Mir-AbouTalebi M; Jabbarvand M
    J Cataract Refract Surg; 2014 Jun; 40(6):937-42. PubMed ID: 24726159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial.
    Nassiri N; Farahangiz S; Rahnavardi M; Rahmani L; Nassiri N
    J Cataract Refract Surg; 2008 Jun; 34(6):902-8. PubMed ID: 18498993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia.
    Sia RK; Ryan DS; Edwards JD; Stutzman RD; Bower KS
    J Refract Surg; 2014 Apr; 30(4):256-64. PubMed ID: 24702577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes.
    Gambato C; Ghirlando A; Moretto E; Busato F; Midena E
    Ophthalmology; 2005 Feb; 112(2):208-18; discussion 219. PubMed ID: 15691552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral-eye study of surface refractive treatments: clinical and confocal microscopy evaluation.
    Diakonis VF; Kankariya VP; Kounis G; Pallikaris AI; Yoo SH; Pallikaris IG; Kymionis GD
    J Cataract Refract Surg; 2014 Feb; 40(2):224-31. PubMed ID: 24373376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced application time for prophylactic mitomycin C in photorefractive keratectomy.
    Virasch VV; Majmudar PA; Epstein RJ; Vaidya NS; Dennis RF
    Ophthalmology; 2010 May; 117(5):885-9. PubMed ID: 20163867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia.
    Adib-Moghaddam S; Soleyman-Jahi S; Tefagh G; Tofighi S; Grentzelos MA; Kymionis GD
    J Refract Surg; 2018 Jun; 34(6):400-407. PubMed ID: 29889293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C in photorefractive keratectomy: effect on epithelialization and predictability.
    Leccisotti A
    Cornea; 2008 Apr; 27(3):288-91. PubMed ID: 18362654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin.
    Diakonis VF; Pallikaris A; Kymionis GD; Markomanolakis MM
    Am J Ophthalmol; 2007 Jul; 144(1):99-103. PubMed ID: 17509511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia.
    Thornton I; Xu M; Krueger RR
    J Refract Surg; 2008 Jan; 24(1):S68-76. PubMed ID: 18269154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.
    Kremer I; Ehrenberg M; Levinger S
    Acta Ophthalmol; 2012 May; 90(3):271-6. PubMed ID: 20456254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photorefractive keratectomy with mitomycin C after deep anterior lamellar keratoplasty for keratoconus.
    Leccisotti A
    Cornea; 2008 May; 27(4):417-20. PubMed ID: 18434844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin-C in hyperopic photorefractive keratectomy.
    Leccisotti A
    J Cataract Refract Surg; 2009 Apr; 35(4):682-7. PubMed ID: 19304089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy.
    Morales AJ; Zadok D; Mora-Retana R; Martínez-Gama E; Robledo NE; Chayet AS
    Am J Ophthalmol; 2006 Sep; 142(3):400-4. PubMed ID: 16935583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photorefractive keratectomy with mitomycin-C for consecutive hyperopia after radial keratotomy.
    Anbar R; Malta JB; Barbosa JB; Leoratti MC; Beer S; Campos M
    Cornea; 2009 May; 28(4):371-4. PubMed ID: 19411953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors.
    Kaiserman I; Sadi N; Mimouni M; Sela T; Munzer G; Levartovsky S
    Cornea; 2017 Aug; 36(8):961-966. PubMed ID: 28542088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mitomycin-C on the corneal endothelium during excimer laser surface ablation.
    de Benito-Llopis L; Teus MA; Ortega M
    J Cataract Refract Surg; 2007 Jun; 33(6):1009-13. PubMed ID: 17531695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of mitomycin C on tear function after photorefractive keratectomy: a contralateral comparative study.
    Farahi A; Hashemi H; Mehravaran S
    J Refract Surg; 2013 Apr; 29(4):260-4. PubMed ID: 23557224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.